Uncategorized

Financial services company Perpetual (ASX:PPT) has provided an update on its proposed scheme of arrangement with global investment firm Kohlberg Kravis Roberts & Co (KKR), revealing that tax complications could reduce shareholder cash proceeds and increase the Perpetual’s potential tax liability to between $493m and $529m. This includes a possible $488m primary tax liability. The […]

Develop Global (ASX:DVP) has completed the documentation for a loan facility of approximately A$100m with Trafigura, supporting the restart of its flagship Woodlawn copper-zinc mine in New South Wales. The facility, which includes a five-year offtake agreement, will fund the recommissioning of the mine and accelerate its return to production. Trafigura Group Pte Ltd, headquartered

Visioneering Technologies (ASX:VTI) has announced plans to delist from the Australian Securities Exchange (ASX), with a vote on the proposal scheduled for a special meeting of stockholders on 10 January 2025. The company’s board believes the delisting is in the best interests of the company and its securityholders, citing challenges related to liquidity, valuation, and

Integral Diagnostics (ASX:IDX), which operates diagnostic imaging services in Australia and New Zealand, has secured clearance from the Australian Competition and Consumer Commission (ACCC) for its proposed acquisition of Capitol Health (ASX:CAJ), subject to the divestment of a key clinic in Melton, Victoria. Capitol Health, headquartered in Melbourne, operates diagnostic imaging services across Victoria, Tasmania, South

Immutep (ASX:IMM) has announced the initiation of its TACTI-004 Phase III clinical trial, which aims to evaluate the efficacy of its lead immunotherapy candidate, eftilagimod alfa (“efti”), in treating first-line metastatic non-small cell lung cancer (NSCLC). Efti will be used in combination with Merck’s Keytruda (pembrolizumab) and chemotherapy. This will be compared to the standard treatment of

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses the cash rate. Key points: At its December meeting the RBA left the cash rate on hold at 4.35% as widely expected, leaving it unchanged for 13 months now. The RBA’s rates guidance pivoted to be more dovish though. It continues to

US markets have pulled back from recent highs, with tech stocks leading the decline. The S&P 500 fell 0.61% to 6,052.85, while the Nasdaq dropped 0.62% to 19,736.69. The Dow Jones lost 241 points, closing at 44,401.93. Chipmakers were hit hard, with Nvidia falling 2.6% after China announced an anti-monopoly probe into the company. Advanced

Oil prices have risen slightly following the ousting of Syrian President Bashar al-Assad, but the broader reaction has been muted. Brent crude has increased by 1.15% to US$71.94 per barrel, while West Texas Intermediate has risen 1.41% to US$68.15 per barrel on Monday. The shift follows three consecutive sessions of declines for both benchmarks. While

Wall Street ended the week with record highs for the S&P 500 and Nasdaq Composite. The S&P 500 rose 0.25% to 6,090.27, while the Nasdaq climbed 0.81% to 19,859.77, driven by gains in Tesla, Meta, and Amazon. The Dow Jones Industrial Average moved in the opposite direction, falling 0.28% to 44,642.52. The S&P 500 and

Bhagwan Marine (ASX:BWN) has projected a significant rise in earnings for the first half of FY25, as well as strong tendering activity, with pro-forma EBITDA expected to reach between $26m and $28m. This represents an increase of 26% to 36% compared to the prior corresponding period’s $20.6m. The company attributes this growth to robust performance